1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Diagnostics Focus JULY 2015

Diagnostics Focus JULY 2015

  • July 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Increased Targeting Will Lead To Super Niche Cancer Markets
Industry Brief - Roche To Provide HIV Diagnostic Solutions To Global Fund
Industry Brief - Hitachi/QIAGEN Enter Molecular Testing Collaboration
Industry Trend Analysis - Virtual Diagnostic Testing Adds Scale To HealthTap's Service
Industry Brief - GenomeDx Signs Exclusive Marketing Deal For Decipher In Israel/Palestine
Industry Brief - Cancer Genetics Teams Up With ICON's Laboratory Services
Industry Brief - Seegene To Develop Molecular Diagnostic Assays For QIAGEN's Rotor-Gene Q
Industry Trend Analysis - Sequenom Appeal Failure Implies Wider Market Changes
Industry Brief - Quintiles/Quest Launch Q2 Solutions
Industry Brief - Eurofins To Acquire 75% Stake In Emory Genetics Laboratory
Industry Brief - Quest To Acquire MemorialCare Health System's Laboratory Outreach Service Business
Industry Trend Analysis - Natera's IPO Signals Shift In NIPT Market
Industry Brief - Diagnostics 510(k) Clearances - June 2015
Industry Brief - Vitros Chemistry Products HbA1c Reagent Kit FDA-Cleared
Industry Brief - Asuragen Launches Quantidex Pan Cancer Kit
Industry Brief - Roche Launches Cardiac PoC Troponin T Test
Industry Brief - 4Kscore Test Recommended In NCCN Prostate Cancer Early Detection Guidelines
Industry Brief - PathGroup Offers Cancer-Specific SmartGenomics Testing In US
Industry Brief - CellDetect Non-Invasive BC Test CE-Marked
Industry Brief - Novacyt Offers Molecular HPV Service For NOVAprep Customers
Industry Brief - SkylineDx Launches MMProfiler Assay For MM Prognosis
Industry Brief - Solana Molecular System/Group A Strep Assay FDA-Cleared
Industry Brief - Idylla KRAS Mutation Test Launched In Europe
Industry Brief - Biomerica's Clinical Laboratory Products Approved In Brazil
Industry Brief - Theranos' HSV-1 IgG Test/System Gain US Marketing Green Light
Industry Brief - Biocept Launches Blood-Based FGFr1 Test Menu
Industry Brief - Architect Galectin-3 Assay Available In US
Industry Brief - Great Basin's GBS Test Now Available In US
Industry Trend Analysis - Iressa's US Return Will Be Further Enhanced By Liquid Biopsy
Industry Brief - LamdaGen Granted EU Patent Allowance
Industry Brief - ACD Raises Funds To Accelerate Commercialisation Of New Technology Platforms
Industry Brief - Firefly Dx Pathogen Detection System Successful In 12 Different Assays
Industry Brief - Breath Test Developed To Detect Oesophageal/Gastric cancers
Industry Brief - Xagenic Raises Funds To Support Xagenic X1 Platform
Industry Brief - Natera Selected For TRACERx Study Of LC Heterogeneity Using ctDNA
Industry Brief - Cellsearch System Shows Feasibility Of Liquid Biopsy In Breast Cancer
Industry Brief - Diagnostic Conferences - July 2015

Table Of Contents

Diagnostics Focus JULY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Lung Cancer: Analytical Tool

August 2016 $ 8096

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.